KFDA Under Fire Over Dawdle In Fight Against Asbestos-tainted Talc Pills
This article was originally published in PharmAsia News
SEOUL - South Korea's FDA is under fire after announcing it would expand a probe into pharmaceutical pills to determine how asbestos-tainted talc was used to prevent the pills from sticking to each other in the production process
You may also be interested in...
KFDA To Ban 1000-plus Generic Drugs In New Blow To Korea's Domestic Pharmaceutical Companies, Potential Boost For Innovative Medicines
SEOUL - As regulators tighten checks for safety and effectiveness on South Korea's generic drugs, they have marked 1,226 products, or 58.5 percent of the 2,095 drugs examined, for elimination from the market